Drugs and Society - Hanson, Glen R; Venturelli, Peter J; Platteborze, Peter
156,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
78 °P sammeln
  • Broschiertes Buch

As a long-standing, reliable resource Drugs & Society, Fifteenth Edition continues to captivate and inform students by taking a multidisciplinary approach to the impact of drug use and abuse on the lives of average individuals. The authors have integrated their expertise in the fields of drug abuse, pharmacology, and sociology with their extensive experiences in research, treatment, drug policy making, and drug policy implementation to create an edition that speaks directly to students on the medical, emotional, and social damage drug use can cause.NEW - Includes new and updated content on…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
As a long-standing, reliable resource Drugs & Society, Fifteenth Edition continues to captivate and inform students by taking a multidisciplinary approach to the impact of drug use and abuse on the lives of average individuals. The authors have integrated their expertise in the fields of drug abuse, pharmacology, and sociology with their extensive experiences in research, treatment, drug policy making, and drug policy implementation to create an edition that speaks directly to students on the medical, emotional, and social damage drug use can cause.NEW - Includes new and updated content on important topics, such as: - The potential value of genetics in assessing risk, consequences, and treatment of drug use disorder or addiction- The abuse and extent of performance-enhancing drugs in athletic and sport activity- Statistics of use and the impact of drugs of abuse- The value of forensic drug testing- Recent findings concerning the extent of vaping and its negative long-term consequences- The escalation of American overdose deaths due to opioids directly related to both prescription abuse and the emergence of illicit fentanyl in counterfeit medications- The pharmacological and behavioral characteristics of alcohol use and abuse including major costs to society- The pattern of methamphetamine resurgence uses in the United States and its trafficking patterns from Mexico, as well as the recent connections between methamphetamine and heroin/opioid use- The use of hallucinogenic drugs such as Ecstasy (MDMA) to treat mental conditions such as posttraumatic stress disorder and the use of ketamine to treat depression- Problems associated with the rapidly escalating drug costs in the U.S. and how to address these challenges- Tobacco regulation by the FDA and the continued increase in the popularity of e-cigarettes- Recent changes in most state marijuana laws in the United States that legally redefine marijuana as medicine for neurological and mental health issues and most recent events to make it a legal drug for recreational marijuana use.Engaging boxed features throughout the text include: Holding the Line: vignettes that help readers assess governmental efforts to deal with drug-related problemsCase in Point: examples of relevant clinical and/or social issues that arise from the use of each major group of drugsHere and Now: current events that illustrate the personal and social consequences of drug abuseFamily Matters: examples of how genetics and heredity contribute to drug abuse Prescription for Abuse: current stories that illustrate the problems of prescription abuse and its consequencesPoint/Counterpoint: exposes students to different perspectives on drug-related issues and encourages them to draw their own conclusions.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Glen R. Hanson is the vice dean of the School of Dentistry and a professor of pharmacology in the School of Dentistry at the University of Utah. He is also the Senior Advisor for the Mountain Plains PTTC (Prevention Technology Transfer Center), which is supported by the Substance Abuse Mental Health Service Administration of the Department of Heath and Human Services. During his approximately 30 years in academics, he has received more than $30 million from the National Institute on Drug Abuse (NIDA), affiliated with the National Institutes of Health (NIH), to research the neurobiology of drug abuse, and he has authored more than 240 scientific papers and 50 book chapters on the subject. Dr. Hanson has lectured on drug abuse topics throughout the world. He served as the director of the Division of Neuroscience and Behavioral Research at NIDA, after which he became NIDA's acting director from 2001 to 2003. Dr. Hanson works with scientists, public officials, policy makers, and the general public to more effectively deal with problems of drug abuse addiction.